oxprenolol has been researched along with Chronic Illness in 12 studies
Oxprenolol: A beta-adrenergic antagonist used in the treatment of hypertension, angina pectoris, arrhythmias, and anxiety.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We have treated eleven patients with chronic stable angina pectoris with slow-release oxprenolol (160 mg and 320 mg) in a double-blind crossover study and evaluated its efficacy objectively by exercise testing between 180 and 240 min after dosing." | 9.06 | Evaluation of oxprenolol slow release and osmotic release by exercise testing and ambulatory electrocardiographic monitoring in patients with chronic stable angina pectoris. ( Bowles, MJ; Khurmi, NS; O'Hara, MJ; Raftery, EB, 1987) |
| " In more than 50 percent of the cases of initial tremor induced by lithium therapy, oxprenolol in daily doses of 160--240 mg produced good effects and moderate improvement was noted in a few further cases." | 9.04 | Therapy of extrapyramidal side effects, with particular reference to persistent dyskinesia and lithium tremor. ( Pöldinger, W, 1978) |
| "1 The effects of atenolol (50 mg and 100 mg) and oxprenolol (80 mg) on respiratory function were studied in ten patients with angina pectoris or hypertension complicated by chronic airways obstruction." | 9.04 | Comparison of atenolol and oxprenolol in patients with angina or hypertension and co-existent chronic airways obstruction. ( Chatterjee, SS; Croxson, RS; Cruickshank, JM; Perks, WH, 1978) |
| "We have treated eleven patients with chronic stable angina pectoris with slow-release oxprenolol (160 mg and 320 mg) in a double-blind crossover study and evaluated its efficacy objectively by exercise testing between 180 and 240 min after dosing." | 5.06 | Evaluation of oxprenolol slow release and osmotic release by exercise testing and ambulatory electrocardiographic monitoring in patients with chronic stable angina pectoris. ( Bowles, MJ; Khurmi, NS; O'Hara, MJ; Raftery, EB, 1987) |
| " In more than 50 percent of the cases of initial tremor induced by lithium therapy, oxprenolol in daily doses of 160--240 mg produced good effects and moderate improvement was noted in a few further cases." | 5.04 | Therapy of extrapyramidal side effects, with particular reference to persistent dyskinesia and lithium tremor. ( Pöldinger, W, 1978) |
| "1 The effects of atenolol (50 mg and 100 mg) and oxprenolol (80 mg) on respiratory function were studied in ten patients with angina pectoris or hypertension complicated by chronic airways obstruction." | 5.04 | Comparison of atenolol and oxprenolol in patients with angina or hypertension and co-existent chronic airways obstruction. ( Chatterjee, SS; Croxson, RS; Cruickshank, JM; Perks, WH, 1978) |
| "Oxprenolol is a new beta-adrenergic blocking drug, whose effectiveness in the treatment of various forms of glaucoma has been evaluated." | 3.65 | [Topical oxpernolol in the treatment of various forms of glaucoma (author's transl)]. ( Bietti, GB; Bucci, MG; Pescosolido, N, 1977) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (91.67) | 18.7374 |
| 1990's | 1 (8.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Taylor, SH | 2 |
| Silke, B | 1 |
| Jones, GR | 1 |
| Mir, MA | 1 |
| Steinberg, R | 1 |
| Einhäupl, K | 1 |
| Hippius, H | 1 |
| Hoff, P | 1 |
| Nedopil, N | 1 |
| Oefele, K | 1 |
| Rüther, E | 1 |
| Baronchelli, A | 1 |
| Agosta, R | 1 |
| Verdecchia, P | 1 |
| Bichisao, E | 1 |
| Davidson, C | 1 |
| Thadani, U | 1 |
| Singleton, W | 1 |
| Pöldinger, W | 1 |
| Kendall, MJ | 1 |
| Quarterman, CP | 1 |
| Bishop, H | 1 |
| Schneider, RE | 1 |
| Perks, WH | 1 |
| Chatterjee, SS | 1 |
| Croxson, RS | 1 |
| Cruickshank, JM | 1 |
| Bietti, GB | 1 |
| Bucci, MG | 1 |
| Pescosolido, N | 1 |
| Lopatin, IuM | 1 |
| Ghani, P | 1 |
| Sinitsin, VE | 1 |
| Mareev, VIu | 1 |
| Bowles, MJ | 1 |
| Khurmi, NS | 1 |
| O'Hara, MJ | 1 |
| Raftery, EB | 1 |
| Liutoev, GI | 1 |
| Ermilov, LP | 1 |
8 trials available for oxprenolol and Chronic Illness
| Article | Year |
|---|---|
Comparison of antianginal efficacy of one conventional and three long acting beta-adrenoreceptor blocking agents in stable angina pectoris.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Chronic Disease; Clinical Trials as Topic | 1981 |
[Chronic hyposomnias in ambulatory sleep care service].
Topics: Adult; Ambulatory Care; Chronic Disease; Clinical Trials as Topic; Combined Modality Therapy; Diagno | 1984 |
[Advantages of a fixed association of oxprenolol-chlorthalidone, as opposed to chlorthalidone alone, in the treatment of chronic essential arterial hypertension].
Topics: Adult; Aged; Chlorthalidone; Chronic Disease; Clinical Trials as Topic; Double-Blind Method; Drug Co | 1981 |
Comparison of antihypertensive activity of beta-blocking drugs during chronic treatment.
Topics: Adrenergic beta-Antagonists; Adult; Blood Pressure; Chronic Disease; Clinical Trials as Topic; Dose- | 1976 |
Therapy of extrapyramidal side effects, with particular reference to persistent dyskinesia and lithium tremor.
Topics: Adolescent; Adult; Amantadine; Antipsychotic Agents; Basal Ganglia Diseases; Bromocriptine; Chronic | 1978 |
Comparison of atenolol and oxprenolol in patients with angina or hypertension and co-existent chronic airways obstruction.
Topics: Adult; Airway Obstruction; Angina Pectoris; Atenolol; Chronic Disease; Clinical Trials as Topic; Dou | 1978 |
[Potential possibilities of using adrenergic beta blockers in chronic heart failure].
Topics: Adolescent; Adult; Aged; Chronic Disease; Female; Heart Failure; Hemodynamics; Humans; Male; Metopro | 1992 |
Evaluation of oxprenolol slow release and osmotic release by exercise testing and ambulatory electrocardiographic monitoring in patients with chronic stable angina pectoris.
Topics: Aged; Angina Pectoris; Chronic Disease; Clinical Trials as Topic; Delayed-Action Preparations; Doubl | 1987 |
4 other studies available for oxprenolol and Chronic Illness
| Article | Year |
|---|---|
Haemodynamic effects of beta-blockade in ischaemic heart failure.
Topics: Chronic Disease; Heart Failure; Heart Ventricles; Hemodynamics; Humans; Male; Middle Aged; Oxprenolo | 1981 |
Effects of inflammatory disease on plasma oxprenolol concentrations.
Topics: Adult; Aged; Arthritis, Rheumatoid; Back Pain; Blood Sedimentation; Chronic Disease; Crohn Disease; | 1979 |
[Topical oxpernolol in the treatment of various forms of glaucoma (author's transl)].
Topics: Chronic Disease; Glaucoma; Humans; Intraocular Pressure; Ophthalmic Solutions; Oxprenolol | 1977 |
[Effect of inderal and trasicor on the function of external respiration in chronic coronary insufficiency].
Topics: Acid-Base Equilibrium; Adrenergic beta-Antagonists; Adult; Aged; Chronic Disease; Coronary Disease; | 1973 |